Carregando…
Todas as empresas daqui passadas pelas mesmas cinco verificações sobre crescimento e geração de caixa. Descreve o segmento como ele se divulga hoje — não qual destas comprar.
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | US$ 136,5B | US$ 538,53 | 34,68 | US$ 13B | 30,7% |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | US$ 100,9B | US$ 955,80 | 21,10 | US$ 16,9B | 28,5% |
| MRNA | Moderna, Inc. | C- | US$ 90,3B | US$ 223,22 | — | US$ 2,5B | -110,5% |
| ARGX | ARGENX SE | sem nota | US$ 59,4B | US$ 959,78 | 49,04 | — | — |
| ONC | BEONE MEDICINES LTD. | A+ | US$ 47,6B | US$ 416,41 | 53,39 | US$ 6,6B | 13,9% |
| RPRX | Royalty Pharma plc | C+ | US$ 39,8B | US$ 69,30 | 45,29 | US$ 2,6B | 25,7% |
| RVMD | Revolution Medicines, Inc. | F | US$ 37,3B | US$ 172,27 | — | US$ 0,00 | — |
| ROIV | ROIVANT SCIENCES LTD. | B- | US$ 28,6B | US$ 39,54 | — | US$ 41,1M | -838,2% |
| INSM | INSMED INC | C- | US$ 26,6B | US$ 121,15 | — | US$ 1,5B | -39,9% |
| INCY | INCYTE CORPORATION | C | US$ 24,7B | US$ 120,94 | 64,33 | US$ 6B | 6,7% |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | B+ | US$ 22,1B | US$ 165,05 | 70,84 | US$ 3,7B | 71,3% |
| BNTX | BioNTech SE | F | US$ 21,5B | US$ 85,57 | — | US$ 2,7B | -60,9% |
| NCNA | NUCANA PLC | sem nota | US$ 18,5B | US$ 0,89 | — | — | — |
| ASND | Ascendis Pharma A/S | D | US$ 17,1B | US$ 275,33 | — | US$ 1,3B | -19,0% |
| EXEL | EXELIXIS, INC. | A+ | US$ 16,8B | US$ 68,99 | 20,66 | US$ 2,5B | 35,5% |
| JAZZ | Jazz Pharmaceuticals plc | A | US$ 15,5B | US$ 241,38 | 78,63 | US$ 4,7B | 4,4% |
| BBIO | BridgeBio Pharma, Inc. | B | US$ 15,3B | US$ 78,31 | — | US$ 945,5M | -60,7% |
| AKTX | Akari Therapeutics, Plc | sem nota | US$ 12,7B | US$ 6,85 | — | — | — |
| TECH | BIO-TECHNE Corp | A+ | US$ 11,4B | US$ 72,80 | 66,79 | US$ 1,2B | 14,0% |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | US$ 11,4B | US$ 100,30 | 25,01 | US$ 1,8B | 26,9% |
| SMMT | Summit Therapeutics Inc. | sem nota | US$ 11,3B | US$ 14,14 | — | — | — |
| BMRN | BioMarin Pharmaceutical Inc | B | US$ 11,1B | US$ 57,22 | — | US$ 3,7B | -0,5% |
| KYMR | KYMERA THERAPEUTICS, INC. | F- | US$ 10,9B | US$ 127,63 | — | US$ 102,2M | -341,8% |
| PCVX | VAXCYTE, INC. | sem nota | US$ 10B | US$ 63,36 | — | — | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | B- | US$ 9,9B | US$ 427,50 | — | US$ 1,4B | -10,9% |
| SYRE | SPYRE THERAPEUTICS, INC. | D | US$ 9,9B | US$ 104,01 | — | US$ 0,00 | — |
| TGTX | TG THERAPEUTICS, INC. | A+ | US$ 9,7B | US$ 64,49 | 96,25 | US$ 897,8M | 11,8% |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | US$ 9,2B | US$ 327,93 | — | US$ 0,00 | — |
| KRYS | Krystal Biotech, Inc. | A+ | US$ 9B | US$ 304,96 | 41,38 | US$ 470M | 47,9% |
| PTGX | PROTAGONIST THERAPEUTICS, INC. | A+ | US$ 8,5B | US$ 130,83 | 27,78 | US$ 551,7M | 62,0% |
| CORT | CORCEPT THERAPEUTICS INC | A+ | US$ 8B | US$ 72,94 | 57,43 | US$ 963,6M | 16,8% |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | US$ 8B | US$ 115,03 | — | US$ 280,7M | -69,0% |
| CYTK | CYTOKINETICS, INCORPORATED | D | US$ 7,8B | US$ 56,14 | — | US$ 113,3M | -686,6% |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | US$ 7,4B | US$ 141,54 | — | US$ 865,3M | -18,2% |
| KOD | KODIAK SCIENCES INC. | sem nota | US$ 7,3B | US$ 111,19 | — | — | — |
| ORKA | Oruka Therapeutics, Inc. | sem nota | US$ 7,1B | US$ 105,34 | — | — | — |
| IMVT | Immunovant, Inc. | sem nota | US$ 7,1B | US$ 34,19 | — | — | — |
| TWST | Twist Bioscience Corporation | C- | US$ 7B | US$ 111,56 | — | US$ 459,4M | -28,3% |
| ABVX | Abivax S.A. | sem nota | US$ 6,9B | US$ 87,63 | — | — | — |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | F- | US$ 6,8B | US$ 47,77 | — | US$ 450,8M | -160,6% |
| CGON | CG Oncology, Inc. | F- | US$ 6,6B | US$ 74,35 | — | US$ 6,2M | -3.851,1% |
| CAI | CARIS LIFE SCIENCES, INC. | A | US$ 6,6B | US$ 23,05 | 13,89 | US$ 1B | 9,2% |
| BLTE | Belite Bio, Inc | sem nota | US$ 6,5B | US$ 164,03 | — | — | — |
| IBRX | IMMUNITYBIO, INC. | C | US$ 6,4B | US$ 6,01 | — | US$ 182,6M | -607,8% |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | C | US$ 6,2B | US$ 309,05 | 134,37 | US$ 253,8M | 20,3% |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | US$ 6,1B | US$ 94,00 | — | US$ 670,8M | -134,8% |
| ERAS | ERASCA, INC. | sem nota | US$ 5,5B | US$ 15,65 | — | — | — |
| MANE | Veradermics, Inc | sem nota | US$ 5,5B | US$ 129,60 | — | — | — |
| PTCT | PTC Therapeutics, Inc. | D | US$ 5,3B | US$ 63,49 | — | US$ 1,2B | -9,2% |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F- | US$ 5,3B | US$ 43,16 | — | US$ 570K | -72.563,2% |
| DNTH | Dianthus Therapeutics, Inc. | F- | US$ 5,2B | US$ 91,76 | — | US$ 2M | -9.927,5% |
| EWTX | Edgewise Therapeutics, Inc. | sem nota | US$ 5B | US$ 45,97 | 5,62 | — | — |
| COGT | Cogent Biosciences, Inc. | sem nota | US$ 5B | US$ 28,53 | — | — | — |
| TVTX | TRAVERE THERAPEUTICS, INC. | F- | US$ 4,9B | US$ 50,63 | — | US$ 651M | -18,7% |
| IONS | IONIS PHARMACEUTICALS, INC. | F- | US$ 4,8B | US$ 29,06 | — | US$ 960,1M | -56,9% |
| DFTX | Definium Therapeutics, Inc. | sem nota | US$ 4,4B | US$ 32,09 | — | — | — |
| TNGX | TANGO THERAPEUTICS, INC. | F | US$ 4,3B | US$ 25,52 | — | US$ 0,00 | — |
| GPCR | Structure Therapeutics Inc. | sem nota | US$ 4,3B | US$ 20,01 | — | — | — |
| CRSP | CRISPR THERAPEUTICS AG | F- | US$ 4,1B | US$ 42,21 | — | US$ 25,2M | -1.812,1% |
| ZLAB | ZAI LAB LIMITED | F- | US$ 4B | US$ 24,61 | — | US$ 441,7M | -44,9% |
| RLAY | RELAY THERAPEUTICS, INC. | D- | US$ 4B | US$ 18,10 | — | US$ 10,4M | -2.837,0% |
| XENE | Xenon Pharmaceuticals Inc. | F | US$ 4B | US$ 40,49 | — | US$ 0,00 | — |
| TARS | TARSUS PHARMACEUTICALS, INC. | B- | US$ 4B | US$ 80,25 | — | US$ 682,2M | -102,9% |
| ABCL | AbCellera Biologics Inc. | C- | US$ 3,8B | US$ 11,49 | — | US$ 67,9M | -218,5% |
| VKTX | VIKING THERAPEUTICS, INC. | F | US$ 3,7B | US$ 29,25 | — | US$ 0,00 | — |
| IRON | Disc Medicine, Inc. | sem nota | US$ 3,6B | US$ 80,00 | — | — | — |
| ELVN | ENLIVEN THERAPEUTICS, INC. | sem nota | US$ 3,6B | US$ 48,77 | — | — | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | US$ 3,6B | US$ 7,75 | — | US$ 379M | -58,2% |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | B | US$ 3,6B | US$ 28,25 | 134,52 | US$ 508,7M | 5,9% |
| PBLS | Parabilis Medicines, Inc. | sem nota | US$ 3,6B | US$ 28,44 | — | — | — |
| VRDN | Viridian Therapeutics, Inc./DE | F- | US$ 3,5B | US$ 30,86 | — | US$ 26,3M | -1.724,1% |
| DBVT | DBV TECHNOLOGIES S.A. | F- | US$ 3,5B | US$ 11,07 | — | US$ 3,8M | -5.405,3% |
| ACAD | ACADIA PHARMACEUTICALS INC. | B+ | US$ 3,2B | US$ 18,73 | 8,83 | US$ 1,2B | 30,1% |
| LEGN | Legend Biotech Corp | C- | US$ 3,2B | US$ 17,49 | — | US$ 1,1B | -22,0% |
| GMAB | Genmab A/S | B+ | US$ 3,2B | US$ 51,36 | 3,34 | US$ 3,9B | 21,0% |
| DYN | Dyne Therapeutics, Inc. | sem nota | US$ 3,2B | US$ 17,17 | — | — | — |
| CELC | CELCUITY INC. | sem nota | US$ 3,2B | US$ 64,32 | — | — | — |
| TLX | Telix Pharmaceuticals Limited | D | US$ 3,1B | US$ 9,23 | — | US$ 890,8M | 3,8% |
| IDYA | IDEAYA Biosciences, Inc. | F- | US$ 3,1B | US$ 31,82 | — | US$ 36,5M | -1.149,6% |
| ADMA | ADMA BIOLOGICS, INC. | B+ | US$ 3B | US$ 13,69 | 17,78 | US$ 519,2M | 35,1% |
| DNLI | Denali Therapeutics Inc. | F | US$ 3B | US$ 18,74 | — | US$ 0,00 | — |
| VCEL | VERICEL CORPORATION | A | US$ 2,9B | US$ 56,96 | 89,00 | US$ 324,2M | 10,3% |
| XNCR | Xencor, Inc | D- | US$ 2,8B | US$ 37,08 | — | US$ 200,5M | -58,8% |
| MBX | MBX Biosciences, Inc. | sem nota | US$ 2,8B | US$ 55,98 | — | — | — |
| RCUS | Arcus Biosciences, Inc. | F- | US$ 2,5B | US$ 17,43 | — | US$ 100M | -453,0% |
| NAMS | NewAmsterdam Pharma Company N.V. | D- | US$ 2,4B | US$ 20,16 | — | US$ 25,9M | -789,9% |
| BEAM | Beam Therapeutics Inc. | F- | US$ 2,4B | US$ 22,82 | — | US$ 146,6M | -73,9% |
| CLDX | Celldex Therapeutics, Inc. | F- | US$ 2,3B | US$ 28,82 | — | US$ 158K | -195.608,9% |
| LKFT | GALAPAGOS NV | D | US$ 2,2B | US$ 33,95 | 6,31 | US$ 1,2B | 28,9% |
| PVLA | Palvella Therapeutics, Inc. | sem nota | US$ 2,2B | US$ 152,51 | — | — | — |
| IMNM | Immunome Inc. | F | US$ 2,2B | US$ 18,74 | — | US$ 0,00 | — |
| PHVS | Pharvaris N.V. | sem nota | US$ 2,2B | US$ 33,37 | — | — | — |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | US$ 2,1B | US$ 15,73 | 6,87 | US$ 321,7M | 97,7% |
| BHVN | Biohaven Ltd. | sem nota | US$ 2,1B | US$ 13,81 | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | sem nota | US$ 2,1B | US$ 21,90 | — | — | — |
| VERA | Vera Therapeutics, Inc. | sem nota | US$ 2B | US$ 28,11 | — | — | — |
| SEPN | Septerna, Inc. | F- | US$ 2B | US$ 42,61 | — | US$ 96,3M | -61,3% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | B+ | US$ 2B | US$ 33,76 | 11,14 | US$ 989,4M | 18,1% |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | sem nota | US$ 2B | US$ 47,15 | — | — | — |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | US$ 2B | US$ 3,18 | — | US$ 68,2M | -697,1% |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | US$ 2B | US$ 7,54 | — | US$ 213M | -30,8% |
| FTRE | Fortrea Holdings Inc. | C | US$ 1,9B | US$ 20,20 | — | US$ 2,7B | -2,6% |
| TRVI | TREVI THERAPEUTICS, INC. | sem nota | US$ 1,9B | US$ 13,65 | — | — | — |
| COAG | Hemab Therapeutics Holdings, Inc. | sem nota | US$ 1,9B | US$ 40,79 | — | — | — |
| ZBIO | Zenas BioPharma, Inc. | F- | US$ 1,9B | US$ 27,99 | — | US$ 10M | -5.418,1% |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | US$ 1,9B | US$ 31,57 | — | US$ 140,8M | -264,8% |
| MAZE | MAZE THERAPEUTICS, INC. | sem nota | US$ 1,9B | US$ 34,29 | — | — | — |
| ZYME | ZYMEWORKS INC. | F+ | US$ 1,8B | US$ 26,24 | 50,46 | US$ 266M | 16,3% |
| BRVE | Braveheart Bio, Inc. | sem nota | US$ 1,8B | US$ 19,67 | — | — | — |
| STOK | Stoke Therapeutics, Inc. | F- | US$ 1,7B | US$ 26,66 | — | US$ 28,2M | -862,1% |
| SRPT | SAREPTA THERAPEUTICS, INC. | C | US$ 1,7B | US$ 16,07 | — | US$ 2B | -5,9% |
| KLRA | Kailera Therapeutics, Inc. | sem nota | US$ 1,7B | US$ 13,26 | — | — | — |
| MESO | MESOBLAST LIMITED | C- | US$ 1,7B | US$ 13,25 | — | US$ 65,4M | -144,3% |
| VIR | Vir Biotechnology, Inc. | C- | US$ 1,7B | US$ 9,96 | — | US$ 302,8M | -61,0% |
| NRIX | NURIX THERAPEUTICS, INC. | A+ | US$ 1,7B | US$ 15,47 | 6,72 | US$ 701,9M | 42,0% |
| QURE | uniQure N.V. | F- | US$ 1,7B | US$ 23,84 | — | US$ 20,2M | -1.154,8% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | US$ 1,6B | US$ 16,07 | — | US$ 730M | -71,8% |
| PGEN | PRECIGEN, INC. | C | US$ 1,6B | US$ 4,52 | 45,20 | US$ 156,9M | 15,6% |
| SLS | SELLAS Life Sciences Group, Inc. | sem nota | US$ 1,6B | US$ 7,87 | — | — | — |
| GENB | Generate Biomedicines, Inc. | sem nota | US$ 1,6B | US$ 12,06 | — | — | — |
| RAPP | Rapport Therapeutics, Inc. | sem nota | US$ 1,6B | US$ 26,16 | — | — | — |
| IMCR | Immunocore Holdings plc | F- | US$ 1,5B | US$ 29,99 | — | US$ 429,3M | -7,5% |
| NBTX | Nanobiotix S.A. | C- | US$ 1,5B | US$ 30,34 | — | US$ 36,4M | -73,5% |
| ABSI | ABSCI CORP | F- | US$ 1,5B | US$ 8,45 | — | US$ 1,5M | -8.451,3% |
| NUVB | Nuvation Bio Inc. | C- | US$ 1,4B | US$ 3,99 | — | US$ 201,7M | -67,4% |
| NVAX | NOVAVAX, INC. | F | US$ 1,4B | US$ 8,53 | — | US$ 411,6M | -18,6% |
| LBRX | LB Pharmaceuticals Inc | sem nota | US$ 1,4B | US$ 42,93 | — | — | — |
| TYRA | TYRA BIOSCIENCES, INC. | sem nota | US$ 1,4B | US$ 20,03 | — | — | — |
| ANAB | ANAPTYSBIO, INC. | D+ | US$ 1,4B | US$ 46,26 | 8,68 | US$ 191,6M | 96,3% |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | D- | US$ 1,4B | US$ 14,71 | — | US$ 96,6M | -193,4% |
| OCUL | OCULAR THERAPEUTIX, INC | F- | US$ 1,4B | US$ 6,20 | — | US$ 50,4M | -648,6% |
| NTLA | INTELLIA THERAPEUTICS, INC. | D- | US$ 1,4B | US$ 9,70 | — | US$ 52,9M | -805,7% |
| MLYS | MINERALYS THERAPEUTICS, INC. | sem nota | US$ 1,4B | US$ 15,32 | — | — | — |
| INVA | INNOVIVA, INC. | C+ | US$ 1,4B | US$ 19,03 | 9,51 | US$ 438,3M | 44,1% |
| AVLN | Avalyn Pharma Inc. | sem nota | US$ 1,3B | US$ 30,26 | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | sem nota | US$ 1,3B | US$ 21,61 | — | — | — |
| TSHA | Taysha Gene Therapies, Inc. | F- | US$ 1,3B | US$ 4,09 | — | US$ 5,5M | -2.844,6% |
| MNKD | MannKind Corporation | D | US$ 1,3B | US$ 4,12 | — | US$ 413,4M | -18,1% |
| KARD | Kardigan, Inc. | sem nota | US$ 1,3B | US$ 13,83 | — | — | — |
| URGN | UroGen Pharma Ltd. | C | US$ 1,3B | US$ 26,18 | — | US$ 250,3M | -26,3% |
| NKTR | NEKTAR THERAPEUTICS | F- | US$ 1,3B | US$ 37,29 | — | US$ 52,2M | -339,7% |
| OMER | OMEROS CORP | sem nota | US$ 1,3B | US$ 17,49 | 10,17 | — | — |
| SLN | Silence Therapeutics plc | F- | US$ 1,2B | US$ 19,84 | — | US$ 456K | -11.276,5% |
| INBX | Inhibrx Biosciences, Inc. | D- | US$ 1,2B | US$ 83,17 | — | US$ 1,3M | -10.896,8% |
| VOR | Vor Biopharma Inc. | sem nota | US$ 1,2B | US$ 19,42 | 0,06 | — | — |
| ANRO | Alto Neuroscience, Inc. | sem nota | US$ 1,2B | US$ 29,66 | — | — | — |
| GHRS | GH Research PLC | sem nota | US$ 1,2B | US$ 19,17 | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | sem nota | US$ 1,2B | US$ 13,37 | — | — | — |
| JBIO | Jade Biosciences, Inc. | sem nota | US$ 1,1B | US$ 16,13 | — | — | — |
| SGP | SpyGlass Pharma, Inc. | sem nota | US$ 1,1B | US$ 32,93 | — | — | — |
| SPTX | Seaport Therapeutics, Inc. | sem nota | US$ 1,1B | US$ 19,93 | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | sem nota | US$ 1,1B | US$ 12,51 | — | — | — |
| VSTM | Verastem, Inc. | F- | US$ 1B | US$ 8,19 | — | US$ 100,3M | -178,4% |
| SVRA | Savara Inc. | sem nota | US$ 1B | US$ 4,64 | — | — | — |
| AKTS | Aktis Oncology, Inc. | sem nota | US$ 928,5M | US$ 16,64 | — | — | — |
| ODTX | Odyssey Therapeutics, Inc. | sem nota | US$ 918,1M | US$ 19,10 | — | — | — |
| PHAR | Pharming Group N.V. | A | US$ 912,9M | US$ 13,01 | 325,25 | US$ 376,1M | 0,8% |
| MGTX | MeiraGTx Holdings plc | B | US$ 898,6M | US$ 9,20 | 11,49 | US$ 401,9M | 19,5% |
| CRVS | Corvus Pharmaceuticals, Inc. | sem nota | US$ 896,7M | US$ 10,63 | — | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | US$ 884,5M | US$ 12,22 | — | US$ 96,1M | -208,6% |
| LTGO | Latigo Biotherapeutics, Inc. | sem nota | US$ 872,2M | US$ 13,16 | — | — | — |
| IMTX | Immatics N.V. | sem nota | US$ 857,4M | US$ 6,40 | — | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | US$ 843M | US$ 9,44 | — | US$ 289,7M | -72,3% |
| RIGL | RIGEL PHARMACEUTICALS INC | B+ | US$ 838,9M | US$ 44,55 | 2,77 | US$ 288,2M | 106,6% |
| ORIC | ORIC PHARMACEUTICALS, INC. | sem nota | US$ 811,6M | US$ 7,83 | — | — | — |
| ANNX | ANNEXON, INC. | sem nota | US$ 807,7M | US$ 3,93 | — | — | — |
| LXRX | Lexicon Pharmaceuticals, Inc. | D- | US$ 801,4M | US$ 1,80 | — | US$ 38,5M | -161,8% |
| GLUE | Monte Rosa Therapeutics, Inc. | F- | US$ 800,7M | US$ 9,37 | — | US$ 70,3M | -186,2% |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | US$ 777,1M | US$ 12,58 | — | US$ 0,00 | — |
| ARDX | ARDELYX, INC. | C- | US$ 774,2M | US$ 3,08 | — | US$ 468,2M | -11,8% |
| PRME | Prime Medicine, Inc. | B- | US$ 774,1M | US$ 4,26 | — | US$ 4,6M | -3.807,3% |
| SLDB | Solid Biosciences Inc. | sem nota | US$ 763,4M | US$ 6,84 | — | — | — |
| ACHV | Achieve Life Sciences, Inc. | sem nota | US$ 747,1M | US$ 6,79 | — | — | — |
| AURA | AURA BIOSCIENCES, INC. | sem nota | US$ 740M | US$ 7,11 | — | — | — |
| SGMT | Sagimet Biosciences Inc. | sem nota | US$ 729,4M | US$ 10,22 | — | — | — |
| ALMS | Alumis Inc. | F- | US$ 725,7M | US$ 5,59 | — | US$ 7,2M | -5.844,5% |
| OABI | OMNIAB, INC. | B | US$ 715,4M | US$ 4,91 | — | US$ 40,2M | -108,1% |
| KURA | Kura Oncology, Inc. | C- | US$ 713,4M | US$ 7,77 | — | US$ 79,3M | -369,3% |
| IVA | Inventiva S.A. | F | US$ 711,1M | US$ 3,68 | — | US$ 5M | -7.899,6% |
| APMD | Apnimed, Inc. | sem nota | US$ 705,4M | US$ 16,95 | — | — | — |
| NVCT | NUVECTIS PHARMA, INC. | sem nota | US$ 697,4M | US$ 20,28 | — | — | — |
| JANX | Janux Therapeutics, Inc. | C- | US$ 695M | US$ 11,36 | — | US$ 23,3M | -428,7% |
| ATTO | Attovia Therapeutics, Inc. | sem nota | US$ 693,9M | US$ 15,18 | — | — | — |
| AVBP | ARRIVENT BIOPHARMA, INC. | sem nota | US$ 673,4M | US$ 13,02 | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | US$ 670,8M | US$ 10,48 | — | US$ 0,00 | — |
| CGEM | CULLINAN THERAPEUTICS, INC. | sem nota | US$ 667,1M | US$ 10,28 | — | — | — |
| BCAX | BICARA THERAPEUTICS INC. | sem nota | US$ 665,9M | US$ 10,03 | — | — | — |
| OLMA | OLEMA PHARMACEUTICALS, INC. | sem nota | US$ 660,6M | US$ 7,54 | — | — | — |
| IMMX | IMMIX BIOPHARMA, INC. | sem nota | US$ 656,3M | US$ 7,83 | — | — | — |
| ABUS | ARBUTUS BIOPHARMA CORP | D+ | US$ 627M | US$ 4,09 | 3,62 | US$ 181,5M | 121,2% |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | F- | US$ 623M | US$ 9,61 | — | US$ 130,8M | -192,0% |
| ACRS | Aclaris Therapeutics, Inc. | F- | US$ 621,8M | US$ 3,92 | — | US$ 6,4M | -1.244,1% |
| GERN | GERON CORP | sem nota | US$ 618,5M | US$ 0,96 | — | — | — |
| WVE | WAVE LIFE SCIENCES, INC. | F- | US$ 618,3M | US$ 3,14 | — | US$ 70,9M | -296,9% |
| CLYM | Climb Bio, Inc. | sem nota | US$ 607,9M | US$ 10,35 | — | — | — |
| SANA | Sana Biotechnology, Inc. | sem nota | US$ 603,8M | US$ 2,02 | — | — | — |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | US$ 569M | US$ 7,23 | — | US$ 31,2M | -182,5% |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | US$ 553,8M | US$ 9,53 | — | US$ 0,00 | — |
| CBIO | Crescent Biopharma, Inc. | D- | US$ 553,5M | US$ 14,23 | — | US$ 15M | -727,6% |
| ENTX | ENTERA BIO LTD. | F | US$ 545,1M | US$ 3,13 | — | US$ 0,00 | — |
| ZVRA | Zevra Therapeutics, Inc. | B+ | US$ 539,1M | US$ 9,06 | 7,61 | US$ 147,8M | 52,8% |
| RGNX | REGENXBIO Inc. | F- | US$ 505,2M | US$ 7,64 | — | US$ 153,9M | -113,9% |
| GYRE | Gyre Therapeutics, Inc. | F- | US$ 495,9M | US$ 4,30 | — | US$ 108,1M | -33,9% |
| NGNE | Neurogene Inc. | F | US$ 495M | US$ 23,91 | — | US$ 0,00 | — |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | US$ 494,3M | US$ 6,08 | — | US$ 274,9M | -30,2% |
| VALN | Valneva SE | F- | US$ 491,1M | US$ 5,66 | — | US$ 174,7M | -73,7% |
| MNPR | Monopar Therapeutics Inc. | F | US$ 488,4M | US$ 72,07 | — | US$ 0,00 | — |
| CADL | CANDEL THERAPEUTICS, INC. | sem nota | US$ 486,4M | US$ 6,20 | — | — | — |
| INDP | Indaptus Therapeutics, Inc. | sem nota | US$ 485,4M | US$ 3,16 | — | — | — |
| DMAC | DIAMEDICA THERAPEUTICS INC. | sem nota | US$ 475,1M | US$ 8,81 | — | — | — |
| STTK | Shattuck Labs, Inc. | F | US$ 472,5M | US$ 4,64 | — | US$ 0,00 | — |
| MDXG | MIMEDX GROUP, INC. | F | US$ 468,4M | US$ 3,21 | — | US$ 303,7M | -6,3% |
| JSPR | Jasper Therapeutics, Inc. | sem nota | US$ 454,9M | US$ 13,67 | — | — | — |
| RLMD | RELMADA THERAPEUTICS, INC. | sem nota | US$ 450,3M | US$ 4,22 | — | — | — |
| AVTX | AVALO THERAPEUTICS, INC. | F- | US$ 448,1M | US$ 7,75 | — | US$ 59K | -150.259,3% |
| BLSM | BlossomHill Therapeutics, Inc. | sem nota | US$ 447,2M | US$ 14,07 | — | — | — |
| ARVN | ARVINAS, INC. | C- | US$ 446,6M | US$ 6,82 | — | US$ 275,3M | -3,5% |
| CTMX | CytomX Therapeutics, Inc. | F- | US$ 443,6M | US$ 2,04 | — | US$ 14M | -609,0% |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | C- | US$ 433,1M | US$ 21,15 | — | US$ 72,3M | -15,4% |
| IRLA | IRulya Therapeutics Inc. | sem nota | US$ 431,3M | US$ 39,78 | — | — | — |
| KRSA | Korsana Biosciences, Inc. | F | US$ 426,1M | US$ 31,50 | — | US$ 1,9M | -3.098,7% |
| TECX | TECTONIC THERAPEUTIC, INC. | sem nota | US$ 419,7M | US$ 21,04 | — | — | — |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | D- | US$ 419,5M | US$ 8,17 | — | US$ 52,7M | -45,4% |
| FENC | FENNEC PHARMACEUTICALS INC. | A | US$ 411,1M | US$ 11,65 | 582,25 | US$ 66,4M | 3,1% |
| OCS | Oculis Holding AG | sem nota | US$ 401,2M | US$ 7,68 | — | — | — |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | US$ 401,2M | US$ 7,76 | 16,87 | US$ 231,8M | 10,3% |
| SPRY | ARS Pharmaceuticals, Inc. | F- | US$ 392,1M | US$ 3,90 | — | US$ 122,1M | -163,6% |
| IRD | Opus Genetics, Inc. | F- | US$ 385,7M | US$ 3,99 | — | US$ 7,9M | -1.726,7% |
| ALEC | Alector, Inc. | B+ | US$ 379,6M | US$ 2,55 | 7,29 | US$ 173,5M | 23,9% |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | sem nota | US$ 371,9M | US$ 1,72 | — | — | — |
| CRMD | CORMEDIX INC. | B+ | US$ 370,2M | US$ 4,66 | 7,76 | US$ 412,5M | 15,5% |
| CCCC | C4 Therapeutics, Inc. | D- | US$ 363,1M | US$ 2,77 | — | US$ 32,3M | -282,2% |
| RZLT | Rezolute, Inc. | sem nota | US$ 353,1M | US$ 3,65 | — | — | — |
| LYEL | Lyell Immunopharma, Inc. | F- | US$ 350,6M | US$ 14,26 | — | US$ 15K | -1.701.066,7% |
| AVIR | Atea Pharmaceuticals, Inc. | sem nota | US$ 345,3M | US$ 4,30 | — | — | — |
| YDES | YD Bio Limited | D | US$ 345,1M | US$ 4,88 | — | US$ 596,8K | -1.392,6% |
| ANL | Adlai Nortye Ltd. | C | US$ 341,2M | US$ 10,67 | — | US$ 5M | -710,6% |
| EDIT | EDITAS MEDICINE, INC. | B- | US$ 334,1M | US$ 2,17 | — | US$ 49,8M | -145,0% |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | US$ 326M | US$ 8,16 | — | US$ 0,00 | — |
| BNTC | BENITEC BIOPHARMA INC. | D | US$ 325,8M | US$ 9,02 | — | US$ 0,00 | — |
| IMUX | Immunic, Inc. | sem nota | US$ 323,5M | US$ 7,56 | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | sem nota | US$ 322,9M | US$ 5,96 | — | — | — |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | US$ 319,8M | US$ 10,98 | — | US$ 65,3M | -96,9% |
| KYTX | Kyverna Therapeutics, Inc. | sem nota | US$ 319,3M | US$ 5,05 | — | — | — |
| ALT | ALTIMMUNE, INC. | D- | US$ 319,1M | US$ 1,64 | — | US$ 41K | -254.522,0% |
| XFOR | X4 PHARMACEUTICALS, INC | D- | US$ 318,6M | US$ 3,12 | — | US$ 17M | -474,7% |
| EVMN | Evommune, Inc. | F | US$ 315,5M | US$ 7,63 | — | US$ 0,00 | — |
| PROK | ProKidney Corp. | F- | US$ 314,5M | US$ 1,04 | — | US$ 775K | -13.326,7% |
| LRMR | LARIMAR THERAPEUTICS, INC. | sem nota | US$ 312,7M | US$ 3,01 | — | — | — |
| SCTX | SCRIBE THERAPEUTICS INC. | sem nota | US$ 310,2M | US$ 16,38 | — | — | — |
| AUTL | AUTOLUS THERAPEUTICS PLC | C- | US$ 309M | US$ 1,16 | — | US$ 137,4M | -186,4% |
| VERU | VERU INC. | sem nota | US$ 308,9M | US$ 2,11 | — | — | — |
| GALT | GALECTIN THERAPEUTICS INC. | sem nota | US$ 308,6M | US$ 3,06 | — | — | — |
| HELP | CYBIN INC. | sem nota | US$ 308M | US$ 8,85 | — | — | — |
| MPLT | MapLight Therapeutics, Inc. | sem nota | US$ 307,7M | US$ 7,25 | — | — | — |
| AGEN | AGENUS INC | D | US$ 304,1M | US$ 6,72 | 10,18 | US$ 133,9M | 23,0% |
| IPSC | Century Therapeutics, Inc. | C- | US$ 301,5M | US$ 1,66 | — | US$ 109,2M | -90,5% |
| PEPG | PEPGEN INC. | sem nota | US$ 301,3M | US$ 4,35 | — | — | — |
| NAUT | NAUTILUS BIOTECHNOLOGY, INC. | sem nota | US$ 295,5M | US$ 2,32 | — | — | — |
| ALLO | Allogene Therapeutics, Inc. | C- | US$ 290,7M | US$ 0,84 | — | US$ 6,9M | -2.513,9% |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | US$ 288M | US$ 3,77 | — | US$ 0,00 | — |
| TTRX | Turn Therapeutics Inc. | sem nota | US$ 285,9M | US$ 9,35 | — | — | — |
| OCGN | OCUGEN, INC. | F | US$ 280,9M | US$ 0,83 | — | US$ 4,8M | -1.367,6% |
| CABA | CABALETTA BIO, INC. | sem nota | US$ 276,1M | US$ 1,28 | — | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | US$ 275,7M | US$ 3,46 | — | US$ 22,4M | -269,7% |
| YARW | YARROW BIOSCIENCE, INC. | D | US$ 274,1M | US$ 17,99 | — | US$ 482K | -3.881,5% |
| INO | INOVIO PHARMACEUTICALS, INC. | C- | US$ 268,8M | US$ 1,44 | — | US$ 298,9K | -23.798,9% |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | US$ 267,6M | US$ 2,97 | — | US$ 0,00 | — |
| QTTB | Q32 Bio Inc. | B | US$ 261,4M | US$ 8,74 | 2,52 | US$ 53,7M | 60,0% |
| FTH | Faeth Therapeutics, Inc. | sem nota | US$ 259,9M | US$ 10,06 | — | — | — |
| PLX | PROTALIX BIOTHERAPEUTICS, INC. | A+ | US$ 257,2M | US$ 3,05 | 12,20 | US$ 84,7M | 24,3% |
| RCKT | Rocket Pharmaceuticals, Inc. | D | US$ 255,1M | US$ 2,29 | — | US$ 0,00 | — |
| VOGX | Vogenx, Inc. | sem nota | US$ 252,1M | US$ 16,97 | — | — | — |
| CUVL | CLINUVEL PHARMACEUTICALS LIMITED | C+ | US$ 250,6M | US$ 4,97 | 10,80 | US$ 64,3M | 36,0% |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | US$ 241,9M | US$ 4,00 | — | US$ 229,3M | -119,9% |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | US$ 240,4M | US$ 8,34 | — | US$ 30,5M | -285,9% |
| IMRX | Immuneering Corporation | sem nota | US$ 240,1M | US$ 3,71 | — | — | — |
| CAMP | CAMP4 Therapeutics Corporation | B- | US$ 236,6M | US$ 3,77 | — | US$ 5,3M | -2.276,3% |
| LXEO | Lexeo Therapeutics, Inc. | sem nota | US$ 235,5M | US$ 2,87 | — | — | — |
| BCYC | Bicycle Therapeutics plc | C- | US$ 234,4M | US$ 3,35 | — | US$ 83,5M | -169,8% |
| LCTX | Lineage Cell Therapeutics, Inc. | F | US$ 229,4M | US$ 0,91 | — | US$ 10,8M | 16,2% |
| CTNM | Contineum Therapeutics, Inc. | sem nota | US$ 227,8M | US$ 9,86 | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | sem nota | US$ 227,6M | US$ 14,11 | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | sem nota | US$ 219,2M | US$ 14,94 | — | — | — |
| ACIU | AC IMMUNE SA | D- | US$ 216,2M | US$ 2,13 | — | US$ 4,5M | -1.903,0% |
| IKT | INHIBIKASE THERAPEUTICS, INC. | F | US$ 213,2M | US$ 1,52 | — | US$ 0,00 | — |
| DTIL | PRECISION BIOSCIENCES INC | D- | US$ 211,3M | US$ 7,57 | — | US$ 45M | -85,6% |
| KROS | KEROS THERAPEUTICS, INC. | F- | US$ 202,7M | US$ 10,33 | — | US$ 40,8M | -151,4% |
| PALI | PALISADE BIO, INC. | F- | US$ 199,9M | US$ 1,12 | — | US$ 500K | -8.739,2% |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | US$ 198,9M | US$ 5,08 | — | US$ 4M | -4.058,0% |
| CGEN | COMPUGEN LTD | B+ | US$ 198,6M | US$ 2,10 | 5,53 | US$ 75,9M | 47,9% |
| ARTV | Artiva Biotherapeutics, Inc. | F- | US$ 198,2M | US$ 4,01 | — | US$ 0,00 | — |
| ALPS | ALPS GROUP INC | sem nota | US$ 198M | US$ 1,19 | — | — | — |
| LIMN | LIMINATUS PHARMA, INC. | sem nota | US$ 196,1M | US$ 2,92 | — | — | — |
| RNAC | Cartesian Therapeutics, Inc. | F | US$ 193,7M | US$ 6,35 | — | US$ 1M | -12.435,2% |
| PYXS | Pyxis Oncology, Inc. | D- | US$ 189M | US$ 1,58 | — | US$ 13,9M | -625,7% |
| KRRO | Korro Bio, Inc. | D- | US$ 186,3M | US$ 13,57 | — | US$ 1,3M | -8.214,5% |
| ACOG | Alpha Cognition Inc. | D- | US$ 184,4M | US$ 8,37 | — | US$ 20,2M | -144,6% |
| OVID | Ovid Therapeutics Inc. | D- | US$ 181M | US$ 2,55 | — | US$ 1,5M | -2.971,3% |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | US$ 180,6M | US$ 3,06 | — | US$ 0,00 | — |
| ELDN | ELEDON PHARMACEUTICALS, INC. | sem nota | US$ 178,2M | US$ 2,11 | — | — | — |
| ANTX | AN2 Therapeutics, Inc. | sem nota | US$ 173,4M | US$ 4,57 | — | — | — |
| IVVD | INVIVYD, INC. | D- | US$ 171,8M | US$ 0,58 | — | US$ 58,4M | -183,9% |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | sem nota | US$ 171,3M | US$ 2,14 | — | — | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | US$ 167,1M | US$ 1,70 | — | US$ 0,00 | — |
| MDWD | MEDIWOUND LTD. | F- | US$ 165,3M | US$ 12,88 | — | US$ 10M | -235,0% |
| STRO | SUTRO BIOPHARMA, INC. | D | US$ 163,2M | US$ 9,83 | — | US$ 45,1M | -344,2% |
| GTBP | GT Biopharma, Inc. | sem nota | US$ 162,8M | US$ 3,61 | 9,75 | — | — |
| RNA | Atrium Therapeutics, Inc. | sem nota | US$ 162M | US$ 7,51 | — | — | — |
| ENGN | enGene Therapeutics Inc. | sem nota | US$ 161,5M | US$ 2,41 | — | — | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | US$ 160,9M | US$ 3,70 | — | US$ 2M | 7.244,3% |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | sem nota | US$ 159,2M | US$ 23,15 | — | — | — |
| SLGL | Sol-Gel Technologies Ltd. | D | US$ 156M | US$ 56,01 | — | US$ 1,4M | -426,7% |
| TARA | Protara Therapeutics, Inc. | sem nota | US$ 155,5M | US$ 2,53 | — | — | — |
| FATE | FATE THERAPEUTICS INC | F- | US$ 155M | US$ 1,28 | — | US$ 4,8M | -2.619,6% |
| HUMA | Humacyte, Inc. | C- | US$ 154M | US$ 0,55 | — | US$ 2,4M | -3.955,1% |
| UPB | UPSTREAM BIO, INC. | F- | US$ 151,3M | US$ 2,76 | — | US$ 2,9M | -5.712,3% |
| SION | SIONNA THERAPEUTICS, INC. | sem nota | US$ 150,6M | US$ 3,33 | — | — | — |
| NGEN | NERVGEN PHARMA CORP. | sem nota | US$ 149,7M | US$ 1,88 | — | — | — |
| PRQR | ProQR Therapeutics N.V. | C- | US$ 147,5M | US$ 1,40 | — | US$ 22,8M | -204,4% |
| ALXO | ALX ONCOLOGY HOLDINGS INC | sem nota | US$ 143,1M | US$ 1,04 | — | — | — |
| ARMP | ARMATA PHARMACEUTICALS, INC. | sem nota | US$ 142,8M | US$ 3,84 | — | — | — |
| MGNX | MACROGENICS, INC. | D- | US$ 141,9M | US$ 2,22 | — | US$ 154,9M | -33,2% |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | US$ 141,7M | US$ 4,91 | — | US$ 40K | -107.587,6% |
| CMPX | COMPASS THERAPEUTICS, INC. | F | US$ 139,2M | US$ 0,77 | — | US$ 0,00 | — |
| ABEO | ABEONA THERAPEUTICS INC. | C- | US$ 137,7M | US$ 2,41 | — | US$ 39M | -160,3% |
| MENS | Jyong Biotech Ltd. | sem nota | US$ 132,3M | US$ 1,74 | — | — | — |
| IPHA | Innate Pharma SA | F- | US$ 130,3M | US$ 1,39 | — | US$ 10,1M | -546,1% |
| LENZ | LENZ THERAPEUTICS, INC. | F- | US$ 129,8M | US$ 4,13 | — | US$ 12,4M | -1.135,0% |
| CDXS | Codexis, Inc. | B- | US$ 124,4M | US$ 1,14 | — | US$ 88,3M | -21,8% |
| SPRB | Spruce Biosciences, Inc. | F | US$ 123,9M | US$ 43,12 | — | US$ 0,00 | — |
| FHTX | Foghorn Therapeutics Inc. | B | US$ 123,8M | US$ 2,07 | 29,50 | US$ 112,1M | 8,4% |
| CLLS | Cellectis S.A. | F- | US$ 119,8M | US$ 1,20 | — | US$ 25,2M | -506,1% |
| ZURA | Zura Bio Limited | sem nota | US$ 119,4M | US$ 1,24 | — | — | — |
| CUE | Cue Biopharma, Inc. | D- | US$ 117,4M | US$ 16,16 | — | US$ 37,7M | -435,8% |
| NERV | Minerva Neurosciences, Inc. | sem nota | US$ 115,1M | US$ 2,31 | — | — | — |
| PYPD | PolyPid Ltd | sem nota | US$ 114,5M | US$ 6,29 | — | — | — |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | US$ 110,1M | US$ 4,44 | — | US$ 194K | -3.985,6% |
| IBIO | iBio, Inc. | C- | US$ 110M | US$ 0,73 | — | US$ 1,1M | -3.244,2% |
| VYGR | Voyager Therapeutics, Inc. | F- | US$ 107,3M | US$ 1,73 | — | US$ 25,1M | -416,3% |
| OKUR | ONKURE THERAPEUTICS, INC. | sem nota | US$ 106,3M | US$ 2,63 | — | — | — |
| EQ | Equillium, Inc. | sem nota | US$ 106,2M | US$ 1,29 | — | — | — |
| MSLE | Satellos Bioscience Inc. | sem nota | US$ 102,5M | US$ 6,63 | — | — | — |
| ADAG | Adagene Inc. | C- | US$ 101M | US$ 1,71 | — | US$ 7,7M | -229,6% |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | US$ 100,6M | US$ 0,41 | — | -US$ 1,2M | 5.253,5% |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | sem nota | US$ 98,9M | US$ 3,55 | — | — | — |
| ICCC | ImmuCell Corporation | A | US$ 97,6M | US$ 10,74 | 56,53 | US$ 33,2M | 5,7% |
| NBP | NovaBridge Biosciences | sem nota | US$ 96,3M | US$ 0,83 | — | — | — |
| PMVP | PMV PHARMACEUTICALS, INC. | sem nota | US$ 95,6M | US$ 1,27 | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | US$ 92,1M | US$ 1,40 | — | US$ 0,00 | — |
| ANIX | ANIXA BIOSCIENCES, INC. | sem nota | US$ 91,6M | US$ 2,64 | — | — | — |
| VANI | Vivani Medical, Inc. | F | US$ 91,6M | US$ 1,02 | — | US$ 0,00 | — |
| PLYX | Polaryx Therapeutics, Inc. | sem nota | US$ 91,5M | US$ 1,84 | — | — | — |
| SEER | SEER, INC. | F- | US$ 87,6M | US$ 1,57 | — | US$ 14,1M | -450,9% |
| AVXL | ANAVEX LIFE SCIENCES CORP. | sem nota | US$ 86,5M | US$ 0,93 | — | — | — |
| CBUS | Cibus, Inc. | C- | US$ 86,2M | US$ 1,13 | — | US$ 4,5M | -2.131,4% |
| NKTX | Nkarta, Inc. | D | US$ 85,3M | US$ 1,19 | — | US$ 0,00 | — |
| GNLX | GENELUX CORPORATION | F- | US$ 85,1M | US$ 1,88 | — | US$ 8K | -444.950,0% |
| RLYB | RALLYBIO CORPORATION | A | US$ 84,9M | US$ 15,76 | — | US$ 434K | 6.177,4% |
| IFRX | InflaRx N.V. | F- | US$ 84,6M | US$ 1,17 | — | US$ 32,8K | -155.582,1% |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | F | US$ 83,9M | US$ 1,46 | — | US$ 0,00 | — |
| LONA | LeonaBio, Inc. | sem nota | US$ 82,3M | US$ 3,47 | — | — | — |
| CHRS | Coherus Oncology, Inc. | C | US$ 80,7M | US$ 0,52 | — | US$ 53,6M | -253,4% |
| NMRA | NEUMORA THERAPEUTICS, INC. | sem nota | US$ 80,6M | US$ 0,43 | — | — | — |
| ATRA | Atara Biotherapeutics, Inc. | F | US$ 80,5M | US$ 7,90 | — | US$ 4M | -368,6% |
| TNYA | TENAYA THERAPEUTICS, INC. | sem nota | US$ 79,1M | US$ 0,35 | — | — | — |
| NRXS | NEURAXIS, INC. | D- | US$ 78M | US$ 5,50 | — | US$ 6,5M | -185,2% |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | US$ 73,8M | US$ 0,53 | — | US$ 6,6M | -493,0% |
| TENX | TENAX THERAPEUTICS, INC. | F | US$ 73,8M | US$ 1,62 | — | US$ 0,00 | — |
| COYA | Coya Therapeutics, Inc. | F- | US$ 73,2M | US$ 3,12 | — | US$ 4,7M | -643,5% |
| NTRB | NUTRIBAND INC. | F- | US$ 72,3M | US$ 5,95 | — | US$ 1,6M | -430,4% |
| PMCB | PHARMACYTE BIOTECH, INC. | D | US$ 71,7M | US$ 6,68 | — | US$ 0,00 | — |
| MNOV | MEDICINOVA, INC. | D- | US$ 71,2M | US$ 1,39 | — | US$ 935,7K | -1.127,0% |
| OKYO | OKYO Pharma Limited | sem nota | US$ 69,8M | US$ 1,33 | — | — | — |
| FBIO | Fortress Biotech, Inc. | B | US$ 69,7M | US$ 1,88 | — | US$ 70M | 143,0% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | sem nota | US$ 69,7M | US$ 3,38 | — | — | — |
| JAGX | Jaguar Health, Inc. | C | US$ 69,4M | US$ 0,40 | — | US$ 27,8M | -132,2% |
| TLSA | Tiziana Life Sciences Ltd | sem nota | US$ 68,1M | US$ 0,57 | — | — | — |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | US$ 67,9M | US$ 4,88 | — | US$ 60,7M | -1,8% |
| GOSS | GOSSAMER BIO, INC. | B | US$ 67M | US$ 10,95 | — | US$ 78,4M | -159,5% |
| CING | Cingulate Inc. | sem nota | US$ 64,9M | US$ 4,34 | — | — | — |
| MIST | Milestone Pharmaceuticals Inc. | sem nota | US$ 64,8M | US$ 0,52 | — | — | — |
| CGTX | Cognition Therapeutics, Inc. | sem nota | US$ 63,8M | US$ 0,67 | — | — | — |
| ACRV | Acrivon Therapeutics, Inc. | sem nota | US$ 62,1M | US$ 1,45 | — | — | — |
| MAIA | MAIA BIOTECHNOLOGY, INC. | sem nota | US$ 61,8M | US$ 1,00 | — | — | — |
| ETRA | Electra Therapeutics, Inc. | sem nota | US$ 61,7M | US$ 8,96 | — | — | — |
| VRCA | Verrica Pharmaceuticals Inc. | D- | US$ 61,5M | US$ 3,58 | — | US$ 22,9M | -189,2% |
| CNXU | CONEXEU SCIENCES INC. | sem nota | US$ 61,5M | US$ 2,18 | — | — | — |
| XBIT | XBIOTECH INC. | sem nota | US$ 59,5M | US$ 1,95 | — | — | — |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | D- | US$ 59,3M | US$ 0,31 | — | US$ 148,2M | -14,5% |
| BOLD | BOUNDLESS BIO, INC. | sem nota | US$ 59M | US$ 2,50 | — | — | — |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | US$ 58,5M | US$ 3,01 | — | US$ 43M | -420,4% |
| CLGN | CollPlant Biotechnologies Ltd | D- | US$ 58,4M | US$ 4,56 | — | US$ 318K | -4.130,2% |
| SPRO | SPERO THERAPEUTICS, INC. | F- | US$ 57,8M | US$ 0,99 | — | US$ 41,6M | -71,0% |
| XLO | Xilio Therapeutics, Inc. | D- | US$ 57,6M | US$ 8,16 | — | US$ 55M | -20,9% |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | US$ 56,6M | US$ 0,73 | — | US$ 559K | -6.735,2% |
| ANVS | Annovis Bio, Inc. | F | US$ 56,4M | US$ 0,91 | — | US$ 0,00 | — |
| CLNN | Clene Inc. | C | US$ 56,3M | US$ 3,91 | — | US$ 238K | -11.271,4% |
| AZR | Azora Therapeutics, Inc. (DE) | sem nota | US$ 56,1M | US$ 3,93 | — | — | — |
| NRSN | NeuroSense Therapeutics Ltd. | sem nota | US$ 53,1M | US$ 1,63 | — | — | — |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | US$ 51,9M | US$ 12,87 | 1,53 | US$ 0,00 | — |
| ATNM | Actinium Pharmaceuticals, Inc. | D+ | US$ 51,6M | US$ 1,64 | 4,56 | US$ 90K | 12.564,4% |
| RNXT | RENOVORX, INC. | D- | US$ 50,4M | US$ 1,05 | — | US$ 2,8M | -469,0% |
| ONCY | ONCOLYTICS BIOTECH INC. | sem nota | US$ 50,2M | US$ 0,37 | — | — | — |
| MREO | MEREO BIOPHARMA GROUP PLC | C | US$ 49M | US$ 0,31 | — | US$ 500K | -5.387,6% |
| PDSB | PDS Biotechnology Corporation | sem nota | US$ 48,5M | US$ 0,87 | — | — | — |
| INKT | MiNK Therapeutics, Inc. | sem nota | US$ 48,3M | US$ 9,41 | — | — | — |
| HYFT | MindWalk Holdings Corp. | C- | US$ 48,1M | US$ 1,03 | — | US$ 20,1M | -43,6% |
| HOWL | WEREWOLF THERAPEUTICS, INC. | sem nota | US$ 47,6M | US$ 0,98 | — | — | — |
| RNTX | Rein Therapeutics, Inc. | F | US$ 46,9M | US$ 0,54 | — | US$ 0,00 | — |
| GANX | GAIN THERAPEUTICS, INC | sem nota | US$ 46,3M | US$ 1,04 | — | — | — |
| DWTX | Dogwood Therapeutics, Inc. | sem nota | US$ 44,3M | US$ 1,16 | — | — | — |
| IBO | Impact BioMedical, INC. | A | US$ 44,2M | US$ 5,11 | — | US$ 38K | 4.247,4% |
| PLRX | PLIANT THERAPEUTICS, INC. | D | US$ 43,2M | US$ 0,70 | — | US$ 0,00 | — |
| IMA | ImageneBio, Inc. | C- | US$ 43,1M | US$ 3,46 | — | US$ 800K | -5.415,6% |
| CNTB | Connect Biopharma Holdings Limited | C- | US$ 42,6M | US$ 0,68 | — | US$ 3M | -2.336,3% |
| BMEA | Biomea Fusion, Inc. | sem nota | US$ 42,3M | US$ 0,58 | — | — | — |
| ELTX | Elicio Therapeutics, Inc. | sem nota | US$ 42,2M | US$ 1,49 | — | — | — |
| TIL | Instil Bio, Inc. | C- | US$ 41M | US$ 6,05 | — | US$ 9M | -337,7% |
| HYPD | HYPERION DEFI, INC. | B+ | US$ 40,1M | US$ 2,59 | — | US$ 1,9M | 2.075,4% |
| SER | Serina Therapeutics, Inc. | D | US$ 39,9M | US$ 1,50 | — | US$ 260K | -9.421,5% |
| ALDX | ALDEYRA THERAPEUTICS, INC. | sem nota | US$ 39,3M | US$ 0,65 | — | — | — |
| CRBU | Caribou Biosciences, Inc. | F- | US$ 39,2M | US$ 0,36 | — | US$ 9,4M | -1.085,0% |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | US$ 38,5M | US$ 1,51 | — | US$ 357,9K | -3.089,6% |
| TVGN | Tevogen Inc. | sem nota | US$ 38,4M | US$ 5,90 | — | — | — |
| GRCE | Grace Therapeutics, Inc. | sem nota | US$ 38M | US$ 1,81 | — | — | — |
| KLRS | KALARIS THERAPEUTICS, INC. | sem nota | US$ 37,5M | US$ 1,58 | — | — | — |
| EXOZ | EXOZYMES INC. | sem nota | US$ 36,8M | US$ 3,90 | — | — | — |
| TELO | Telomir Pharmaceuticals, Inc. | sem nota | US$ 36,2M | US$ 0,49 | — | — | — |
| OSTX | OS THERAPIES INCORPORATED | sem nota | US$ 34,4M | US$ 0,75 | — | — | — |
| INMB | INMUNE BIO INC. | D- | US$ 32,5M | US$ 1,05 | — | US$ 50K | -33.332,0% |
| NNVC | NANOVIRICIDES, INC. | F | US$ 31,5M | US$ 1,24 | — | US$ 0,00 | — |
| PMN | PROMIS NEUROSCIENCES INC. | sem nota | US$ 29,6M | US$ 3,29 | — | — | — |
| BCTX | BRIACELL THERAPEUTICS CORP. | sem nota | US$ 29,3M | US$ 3,35 | — | — | — |
| AARD | AARDVARK THERAPEUTICS, INC. | F | US$ 29,1M | US$ 1,33 | — | US$ 0,00 | — |
| PTHS | Pelthos Therapeutics Inc. | D- | US$ 28,6M | US$ 7,29 | — | US$ 51,3M | -152,2% |
| NXTC | NextCure, Inc. | sem nota | US$ 28,6M | US$ 6,24 | — | — | — |
| IMMP | Immutep Limited | D- | US$ 26,9M | US$ 3,65 | — | US$ 7,3M | -594,6% |
| GRDX | GridAI Technologies Corp. | F- | US$ 26,7M | US$ 3,74 | — | US$ 36,3K | -56.864,0% |
| MGX | Metagenomi Therapeutics, Inc. | F- | US$ 26,4M | US$ 0,70 | — | US$ 22,3M | -421,8% |
| ALGS | Aligos Therapeutics, Inc. | F- | US$ 26,3M | US$ 2,11 | — | US$ 5,8M | -1.137,2% |
| ACET | Adicet Bio, Inc. | sem nota | US$ 25,8M | US$ 2,76 | — | — | — |
| CRVO | CervoMed Inc. | F- | US$ 25,3M | US$ 1,68 | — | US$ 8,7K | -326.822,5% |
| BYSI | BeyondSpring Inc. | D | US$ 25,2M | US$ 0,61 | — | US$ 0,00 | — |
| LITS | Lite Strategy, Inc. | D | US$ 25,1M | US$ 0,84 | — | US$ 0,00 | — |
| ABVC | ABVC BioPharma, Inc. | D- | US$ 24,5M | US$ 0,91 | — | US$ 296K | -1.322,6% |
| APRE | Aprea Therapeutics, Inc. | sem nota | US$ 23,9M | US$ 0,44 | — | — | — |
| ENLV | Enlivex Ltd. | sem nota | US$ 22,8M | US$ 1,18 | 0,01 | — | — |
| EVAX | Evaxion A/S | B- | US$ 22,8M | US$ 2,74 | — | US$ 7,5M | -102,4% |
| CVM | CEL-SCI CORPORATION | sem nota | US$ 22,3M | US$ 1,27 | — | — | — |
| FLNA | Filana Therapeutics, Inc. | sem nota | US$ 21,4M | US$ 0,43 | — | — | — |
| ATHE | ALTERITY THERAPEUTICS LTD | sem nota | US$ 21,2M | US$ 1,99 | — | — | — |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | sem nota | US$ 20,9M | US$ 0,48 | — | — | — |
| IGC | IGC PHARMA, INC. | C- | US$ 20,7M | US$ 0,18 | — | US$ 1,3M | -560,3% |
| CNSP | CNS Pharmaceuticals, Inc. | sem nota | US$ 20,4M | US$ 2,98 | — | — | — |
| CELU | Celularity Inc. | D | US$ 20,2M | US$ 0,62 | — | US$ 18,7M | -245,7% |
| BSEM | BioStem Technologies, Inc. | sem nota | US$ 20,1M | US$ 1,05 | — | US$ 47,5M | -13,9% |
| APLM | Apollomics Inc. | B | US$ 19,9M | US$ 18,01 | — | US$ 8,5M | -128,7% |
| ATOS | ATOSSA THERAPEUTICS, INC. | sem nota | US$ 19,4M | US$ 1,95 | — | — | — |
| NRXP | NRX Pharmaceuticals, Inc. | B | US$ 19,4M | US$ 2,19 | — | US$ 3,4M | -691,8% |
| COCP | COCRYSTAL PHARMA, INC. | sem nota | US$ 19,4M | US$ 1,01 | — | — | — |
| LPCN | LIPOCINE INC. | D- | US$ 19M | US$ 1,72 | — | US$ 3,7M | -249,2% |
| KTTA | PASITHEA THERAPEUTICS CORP. | sem nota | US$ 19M | US$ 0,52 | — | — | — |
| EDSA | EDESA BIOTECH, INC. | sem nota | US$ 18,7M | US$ 1,94 | — | — | — |
| PLUR | Pluri Inc. | B | US$ 17,3M | US$ 1,20 | — | US$ 1,5M | -1.943,9% |
| CNTX | CONTEXT THERAPEUTICS INC. | sem nota | US$ 17,1M | US$ 0,19 | — | — | — |
| BOLT | Bolt Biotherapeutics, Inc. | F- | US$ 15,9M | US$ 6,09 | — | US$ 2,5M | -1.034,4% |
| TVRD | TVARDI THERAPEUTICS, INC. | F- | US$ 15,8M | US$ 1,18 | — | US$ 7,6M | -352,1% |
| ATYR | ATYR PHARMA, INC. | F- | US$ 15,6M | US$ 6,11 | — | US$ 190K | -28.065,3% |
| ALLR | Allarity Therapeutics, Inc. | C- | US$ 15,5M | US$ 0,97 | — | US$ 350K | -4.493,7% |
| ABOS | Acumen Pharmaceuticals, Inc. | sem nota | US$ 15,4M | US$ 0,21 | — | — | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | US$ 15M | US$ 0,90 | — | US$ 3,9M | -220,5% |
| CTXR | Citius Pharmaceuticals, Inc. | sem nota | US$ 14,7M | US$ 0,54 | — | — | — |
| KYNB | KYNTRA BIO, INC. | F | US$ 14,6M | US$ 3,60 | — | US$ 4,6M | 3.967,8% |
| MCRB | Seres Therapeutics, Inc. | D- | US$ 14,2M | US$ 1,39 | — | US$ 2,1M | -2.209,6% |
| LSTA | LISATA THERAPEUTICS, INC. | F- | US$ 13,5M | US$ 1,25 | — | US$ 100K | -17.159,0% |
| PASG | Passage BIO, Inc. | sem nota | US$ 13,4M | US$ 4,16 | — | — | — |
| DYAI | DYADIC INTERNATIONAL, INC. | D- | US$ 13,3M | US$ 0,33 | — | US$ 3,1M | -226,9% |
| BCDA | BioCardia, Inc. | F | US$ 13M | US$ 0,86 | — | US$ 0,00 | — |
| ONCO | Onconetix, Inc. | F- | US$ 12,6M | US$ 3,20 | — | US$ 645,8K | -1.578,8% |
| NIKI | Niki BioSolutions, Inc. | sem nota | US$ 12,5M | US$ 1,71 | — | — | — |
| NCEL | NewcelX Ltd. | sem nota | US$ 12,5M | US$ 2,60 | — | — | — |
| BIVI | BIOVIE INC. | sem nota | US$ 12,2M | US$ 1,14 | — | — | — |
| GUTS | Fractyl Health, Inc. | F- | US$ 12M | US$ 0,91 | — | US$ 0,00 | — |
| CLRB | Cellectar Biosciences, Inc. | sem nota | US$ 11,4M | US$ 1,14 | — | — | — |
| PTN | PALATIN TECHNOLOGIES, INC. | B- | US$ 11,2M | US$ 6,29 | — | US$ 13,2M | -63,6% |
| HIND | VYOME HOLDINGS, INC. | D- | US$ 11,2M | US$ 1,59 | — | US$ 153,1K | -2.455,6% |
| CMMB | SNOWDRIFT PARENT CORPORATION | sem nota | US$ 11,1M | US$ 1,54 | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | US$ 10,9M | US$ 0,16 | — | US$ 5,2M | -2.219,2% |
| KZIA | Kazia Therapeutics Limited. | F | US$ 10,7M | US$ 6,62 | 5,83 | US$ 29,5K | -54.287,3% |
| INTS | INTENSITY THERAPEUTICS, INC. | sem nota | US$ 10M | US$ 3,03 | — | — | — |
| DARE | Dare Bioscience, Inc. | C- | US$ 9,9M | US$ 0,65 | — | US$ 1,4M | -804,4% |
| GDTC | CytoMed Therapeutics Limited | D- | US$ 9,6M | US$ 0,81 | — | US$ 253,7K | -1.227,1% |
| ICU | SeaStar Medical Holding Corp | D- | US$ 9,3M | US$ 0,82 | — | US$ 2,2M | -678,2% |
| CNSY | CERENOME, INC. | F- | US$ 9,2M | US$ 0,94 | — | US$ 3,5M | -859,5% |
| INAB | IN8BIO, INC. | sem nota | US$ 9M | US$ 0,84 | — | — | — |
| RADX | Radiopharm Theranostics Limited | F- | US$ 8,9M | US$ 0,75 | — | US$ 3,6M | -1.055,3% |
| MTVA | METAVIA INC. | sem nota | US$ 8,7M | US$ 1,29 | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | US$ 8,7M | US$ 8,16 | — | US$ 0,00 | — |
| CALC | CalciMedica, Inc. | sem nota | US$ 8,3M | US$ 1,21 | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | US$ 8,3M | US$ 0,18 | — | US$ 2,4M | -2.474,5% |
| ENSC | ENSYSCE BIOSCIENCES, INC. | F- | US$ 8,1M | US$ 0,42 | — | US$ 6,2M | -1.470,4% |
| AEON | AEON Biopharma, Inc. | sem nota | US$ 7,8M | US$ 0,16 | — | — | — |
| CURX | Curanex Pharmaceuticals Inc | sem nota | US$ 7,5M | US$ 4,79 | — | — | — |
| SNGX | SOLIGENIX, INC. | sem nota | US$ 7,5M | US$ 0,32 | — | — | — |
| TPST | Tempest Therapeutics, Inc. | sem nota | US$ 7,4M | US$ 0,37 | — | — | — |
| ACTU | Actuate Therapeutics, Inc. | sem nota | US$ 7M | US$ 0,29 | — | — | — |
| IMRN | IMMURON LIMITED | D- | US$ 6,9M | US$ 0,86 | — | US$ 5,1M | -71,6% |
| ENVB | ENVERIC BIOSCIENCES, INC. | sem nota | US$ 6,8M | US$ 1,51 | — | — | — |
| TOVX | THERIVA BIOLOGICS, INC. | sem nota | US$ 6,6M | US$ 0,14 | — | — | — |
| XCUR | EXICURE, INC. | F | US$ 6,5M | US$ 1,00 | — | US$ 0,00 | — |
| FBLG | FibroBiologics, Inc. | sem nota | US$ 6,4M | US$ 0,97 | — | — | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | B- | US$ 6,2M | US$ 2,09 | — | US$ 15,2K | -42.721,9% |
| ALZN | ALZAMEND NEURO, INC. | sem nota | US$ 6M | US$ 1,25 | — | — | — |
| AIM | AIM IMMUNOTECH INC. | F | US$ 5,8M | US$ 0,14 | — | US$ 91K | -15.526,4% |
| ACXP | Acurx Pharmaceuticals, Inc. | sem nota | US$ 5,8M | US$ 0,95 | — | — | — |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | sem nota | US$ 5,6M | US$ 0,88 | — | — | — |
| BLRX | BioLineRx Ltd | C- | US$ 5,6M | US$ 1,28 | — | US$ 1,4M | -145,5% |
| LTRN | LANTERN PHARMA INC. | sem nota | US$ 5,5M | US$ 0,43 | — | — | — |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | US$ 5,5M | US$ 1,24 | — | US$ 0,00 | — |
| CVKD | Cadrenal Therapeutics, Inc. | sem nota | US$ 5,4M | US$ 1,51 | — | — | — |
| PCSA | Processa Pharmaceuticals, Inc. | sem nota | US$ 5,3M | US$ 1,90 | — | — | — |
| CMND | Clearmind Medicine Inc. | sem nota | US$ 5,2M | US$ 4,46 | — | — | — |
| SKYE | Skye Bioscience, Inc. | sem nota | US$ 5M | US$ 1,14 | — | — | — |
| ADXN | Addex Therapeutics Ltd | D- | US$ 4,9M | US$ 3,98 | — | US$ 36,4K | -22.448,4% |
| PULM | Pulmatrix, Inc. | C- | US$ 4,6M | US$ 1,26 | — | US$ 7,8M | -51,4% |
| SNTI | Senti Biosciences Holdings, Inc. | F- | US$ 4,4M | US$ 0,14 | — | US$ 55K | -90.116,4% |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | US$ 4,2M | US$ 1,77 | — | US$ 451K | -1.545,2% |
| TCRT | Alaunos Therapeutics, Inc. | D- | US$ 4,1M | US$ 1,63 | — | US$ 3K | -133.666,7% |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | D- | US$ 4M | US$ 0,53 | — | US$ 3K | -249.160,1% |
| XBIO | XENETIC BIOSCIENCES, INC. | F- | US$ 4M | US$ 1,71 | — | US$ 3M | -123,7% |
| TRAW | Traws Pharma, Inc. | D- | US$ 4M | US$ 0,26 | — | US$ 2,8M | -773,0% |
| GRI | GRI Bio, Inc. | sem nota | US$ 4M | US$ 1,82 | — | — | — |
| SILO | SILO PHARMA, INC. | D- | US$ 3,9M | US$ 1,83 | — | US$ 36,1K | -10.319,0% |
| AZTR | Azitra, Inc. | F- | US$ 3,8M | US$ 0,62 | — | US$ 0,00 | — |
| IMNN | Imunon, Inc. | sem nota | US$ 3,7M | US$ 0,58 | — | — | — |
| PHIO | Phio Pharmaceuticals Corp | sem nota | US$ 3,7M | US$ 0,77 | — | — | — |
| AGMB | AgomAb Therapeutics NV | sem nota | US$ 3,4M | US$ 6,27 | — | — | — |
| MBIO | MUSTANG BIO, INC. | sem nota | US$ 3,4M | US$ 0,45 | — | — | — |
| ERNA | Ernexa Therapeutics Inc. | sem nota | US$ 3,1M | US$ 1,85 | — | — | — |
| EVGN | EVOGENE LTD. | F | US$ 3,1M | US$ 0,36 | — | US$ 1,3M | -551,3% |
| REVB | REVELATION BIOSCIENCES, INC. | sem nota | US$ 2,9M | US$ 4,28 | — | — | — |
| DRMA | DERMATA THERAPEUTICS, INC. | sem nota | US$ 2,9M | US$ 0,59 | — | — | — |
| GNPX | Genprex, Inc. | sem nota | US$ 2,8M | US$ 2,09 | — | — | — |
| VIVS | VivoSim Labs, Inc. | C | US$ 2,5M | US$ 0,13 | — | US$ 135K | -7.605,9% |
| VRAX | Virax Biolabs Group Ltd | C- | US$ 2,3M | US$ 0,63 | — | US$ 6,3K | -95.739,2% |
| CLDI | Calidi Biotherapeutics, Inc. | sem nota | US$ 2,2M | US$ 0,63 | — | — | — |
| KAPA | KAIROS PHARMA, LTD. | sem nota | US$ 2,2M | US$ 0,46 | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | sem nota | US$ 2M | US$ 1,95 | — | — | — |
| ARTL | ARTELO BIOSCIENCES, INC. | sem nota | US$ 2M | US$ 2,18 | — | — | — |
| ELAB | PMGC HOLDINGS INC. | D- | US$ 1,9M | US$ 1,63 | — | US$ 4,8M | -275,7% |
| CRIS | CURIS INC | F- | US$ 1,9M | US$ 0,44 | — | US$ 4,3M | -499,4% |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | US$ 1,8M | US$ 0,50 | — | US$ 1,1M | -729,9% |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | US$ 1,8M | US$ 2,28 | — | US$ 21,8K | -42.206,9% |
| PBM | PSYENCE BIOMEDICAL LTD | sem nota | US$ 1,7M | US$ 3,16 | — | — | — |
| HCWB | HCW Biologics Inc. | B- | US$ 1,6M | US$ 0,86 | — | US$ 6,7M | -83,8% |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | US$ 1,4M | US$ 0,41 | — | US$ 3,1M | -270,9% |
| BDRX | Biodexa Pharmaceuticals PLC | sem nota | US$ 1,3M | US$ 2,39 | — | — | — |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | sem nota | US$ 1,3M | US$ 1,32 | — | — | — |
| CANF | Can-Fite BioPharma Ltd. | F- | US$ 1,2M | US$ 1,46 | — | US$ 405K | -2.426,7% |
| BBLG | Bone Biologics Corporation | sem nota | US$ 1,1M | US$ 0,33 | — | — | — |
| APVO | Aptevo Therapeutics Inc. | sem nota | US$ 1,1M | US$ 0,59 | — | — | — |
| GOVX | GEOVAX LABS, INC. | D | US$ 928,3K | US$ 1,71 | — | US$ 0,00 | — |
| OGEN | ORAGENICS, INC. | sem nota | US$ 906,9K | US$ 0,20 | — | — | — |
| DCOY | Decoy Therapeutics Inc. | sem nota | US$ 811,6K | US$ 0,96 | — | — | — |
| HLSQ | BiomX Inc. | sem nota | US$ 739,4K | US$ 0,07 | — | — | — |
| QNRX | Quoin Pharmaceuticals, Ltd. | sem nota | US$ 669,6K | US$ 3,81 | — | — | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | sem nota | US$ 658,5K | US$ 0,28 | — | — | — |
| EDVA | Endovia Health Sciences, Inc. | D | US$ 542,2K | US$ 0,18 | — | US$ 32,1K | -53.856,5% |
| PLRZ | Polyrizon Ltd. | sem nota | US$ 508,2K | US$ 11,21 | 2,29 | — | — |
| VBIO | Valion Bio, Inc. | F- | US$ 461,2K | US$ 0,52 | — | US$ 482K | -3.890,0% |
| SRZN | Surrozen, Inc./DE | D | US$ 370,9K | US$ 31,50 | — | US$ 10,5M | -3.706,4% |
| SLXN | SILEXION THERAPEUTICS CORP | sem nota | US$ 363,4K | US$ 1,97 | — | — | — |
| LGVN | LONGEVERON INC. | F- | US$ 339,1K | US$ 2,45 | — | US$ 1,2M | -1.921,7% |
| CDT | CDT EQUITY INC. | sem nota | US$ 307,4K | US$ 0,39 | — | — | — |
| SPRC | SCISPARC LTD. | F- | US$ 132,6K | US$ 0,36 | — | US$ 679K | -1.793,7% |
| NEUP | Neuphoria Therapeutics Inc. | F- | US$ 76,2K | US$ 2,54 | — | US$ 1,2M | -1.145,7% |
| EYPT | EyePoint, Inc. | F- | US$ 27,6K | US$ 0,31 | — | US$ 2,6M | -13.281,2% |
| KALA | KALA BIO, INC. | F | US$ 10,1K | US$ 0,14 | — | US$ 0,00 | — |
| KPTI | Karyopharm Therapeutics Inc. | C | US$ 503,52 | US$ 0,02 | — | US$ 146,6M | -153,3% |
| PPBT | PURPLE BIOTECH LTD. | sem nota | US$ 370,84 | US$ 1,55 | — | — | — |
| QNTM | Quantum BioPharma Ltd. | sem nota | US$ 19,50 | US$ 1,63 | — | — | — |
| APGE | Apogee Therapeutics, Inc. | sem nota | — | US$ 135,07 | — | — | — |
| ATAI | AtaiBeckley Inc. | sem nota | — | US$ 7,35 | — | US$ 4,1M | -16.142,0% |
| BCAB | BIOATLA, INC. | sem nota | — | US$ 1,74 | — | — | — |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | US$ 0,74 | — | US$ 0,00 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | US$ 84,95 | — | US$ 42,2M | -1.189,9% |
| FBRX | FORTE BIOSCIENCES, INC. | sem nota | — | US$ 76,99 | — | — | — |
| LNAI | LUNAI BIOWORKS INC. | B | — | US$ 0,16 | — | US$ 52K | -6.852,0% |
| MLEC | MOOLEC SCIENCE SA | B | — | US$ 0,85 | — | US$ 333,6M | -52,9% |
| MOLN | MOLECULAR PARTNERS AG | F | — | US$ 3,22 | — | US$ 0,00 | — |
| OSRH | OSR HEALTH, INC. | D- | — | US$ 0,12 | — | US$ 1,7M | -781,5% |
| SLBT | SL Science Holding Ltd | sem nota | — | US$ 0,75 | — | — | — |
| TBPH | Theravance Biopharma, Inc. | C | — | US$ 17,03 | — | US$ 104,3M | 51,6% |
| VCRE | Vicore Pharma Holding AB | sem nota | — | US$ 10,63 | — | — | — |
| VRXA | Veraxa Biotech Holding AG | sem nota | — | US$ 1,12 | — | — | — |
| VTVT | vTv Therapeutics Inc. | C- | — | US$ 19,52 | — | US$ 36,8M | -20,8% |
Fundamentos de documentos entregues à SEC, preços da última coleta de dados de mercado. Ordene por qualquer coluna; empresas sem número vão para o fim nos dois sentidos.
Ordenado por valor de mercado, do maior para o menor; clique em qualquer coluna para reordenar. Empresas sem número vão para o fim nos dois sentidos, porque um P/L faltando significa prejuízo e não que esteja barata. Nada aqui é recomendação.